David C. Myles
Ch. Discov. & Non-Clin Dev Off at Olema Pharmaceuticals, Inc. (OLMA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $4.7M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jan 14SEC | OLMAOlema Pharmaceuticals, Inc. | Sell | 10,000144,846 held (−6%) | $28.34 | $283K | -72.4% |
| Jan 14SEC | OLMAOlema Pharmaceuticals, Inc. | Sell | 49,800542,961 held (−8%) | $27.60 | $1.4M | -71.7% |
| Jan 14SEC | OLMAOlema Pharmaceuticals, Inc. | Sell | 200542,761 held (−0%) | $28.49 | $6K | -72.6% |
| Jan 14SEC | OLMAOlema Pharmaceuticals, Inc. | Sell | 14,997577,764 held (−3%) | $28.60 | $429K | -72.7% |
| Jan 14SEC | OLMAOlema Pharmaceuticals, Inc. | Sell | 35,003542,761 held (−6%) | $28.99 | $1.0M | -73.0% |
| Dec 23SEC | OLMAOlema Pharmaceuticals, Inc. | Sell | 1,225601,656 held (−0%) | $28.08 | $34K | -72.2% |
| Dec 23SEC | OLMAOlema Pharmaceuticals, Inc. | Sell | 43,729557,927 held (−7%) | $30.40 | $1.3M | -74.3% |
| Dec 23SEC | OLMAOlema Pharmaceuticals, Inc. | Sell | 6,046551,881 held (−1%) | $31.39 | $190K | -75.1% |